Intravascular Catheters

Intravascular Catheters Market Outlook

The global intravascular catheters market is projected to reach USD 5.33 billion by 2035, growing at a CAGR of 7.5% during the forecast period from 2025 to 2035. The increasing prevalence of chronic diseases requiring long-term treatment, such as diabetes and cancer, alongside the rising number of surgical procedures, are pivotal factors driving the growth of this market. As advancements in healthcare technology continue to emerge, the demand for efficient and effective vascular access solutions is escalating. Innovations in catheter design, materials, and applications further enhance user experience and patient outcomes, contributing to market expansion. Moreover, the ongoing global focus on improving healthcare infrastructure, particularly in developing regions, is expected to bolster the adoption of intravascular catheters.

Growth Factor of the Market

Several factors are fueling the growth of the intravascular catheters market. The rise in the aging population globally is contributing to an increased incidence of chronic illnesses, necessitating regular medical interventions that utilize catheters. Furthermore, the growing awareness among healthcare professionals regarding the benefits of intravascular access devices is pushing hospitals and clinics to adopt advanced catheter solutions. Technological advancements have led to the development of safer, more efficient catheters that reduce the risk of complications, including infections and thrombosis. Additionally, the surge in outpatient procedures, especially in ambulatory settings, is increasing the demand for versatile catheter options, such as midline and central venous catheters. Finally, substantial investments in healthcare research and development are paving the way for innovative catheter technologies, propelling market growth.

Key Highlights of the Market

• The market is expected to reach USD 5.33 billion by 2035.
• CAGR of 7.5% is projected during the forecast period of 2025-2035.
• The rise in chronic disease prevalence is significantly driving demand.
• Technological advancements are leading to improved catheter designs.
• Increased healthcare investments are fostering innovation in catheter technologies.

By Product Type

Short PIVCs:

Short Peripheral Intravenous Catheters (PIVCs) are integral to the intravascular catheter market, primarily due to their widespread use in clinical settings. These devices are designed for short-term venous access, typically used for fluid administration, blood transfusions, and medication delivery. Their ease of insertion and low cost make them the preferred choice among healthcare providers for emergency and routine procedures. The growing number of outpatient services has led to an increase in the use of short PIVCs, as they facilitate quick and efficient access to the vascular system. Additionally, advancements in catheter materials have enhanced the safety and comfort of short PIVCs, contributing to their rising adoption in various healthcare settings.

Integrated Catheters:

Integrated catheters, which combine various functionalities into a single device, have gained significant popularity in recent years. These catheters often incorporate features such as built-in safety mechanisms and integrated infusion ports, which streamline the process of intravenous therapy and reduce the risk of complications like catheter-related infections. The demand for integrated catheters is particularly driven by the need for enhanced patient safety and comfort, as they minimize the number of punctures and venous accesses required during treatment. The increased focus on infection control in healthcare facilities also boosts the adoption of integrated catheters, making them a crucial segment of the intravascular catheters market.

Midline Catheters:

Midline catheters are gaining traction as versatile vascular access solutions suitable for longer-term use compared to short PIVCs but less invasive than central venous catheters. These catheters can remain in place for extended periods, which is often beneficial for patients requiring lengthy treatments, such as chemotherapy or long-term antibiotic therapy. Their unique design allows for both intravenous therapy and blood draws, contributing to their popularity in outpatient and home healthcare settings. As the trend towards home healthcare continues to rise, the midline catheter segment is expected to see substantial growth, as they provide a balance between comfort, functionality, and safety.

PICCs:

Peripherally Inserted Central Catheters (PICCs) are specifically designed for long-term venous access and are particularly beneficial for patients requiring prolonged treatments. These catheters can be used for administering medications, fluids, and nutrition, making them invaluable in oncology and critical care. The increasing prevalence of chronic conditions requiring long-term intravenous therapy is driving the demand for PICCs. Additionally, advancements in insertion techniques and catheter materials have improved patient outcomes and reduced complications associated with PICC use, leading to higher adoption rates among healthcare providers. As a result, the PICC segment is anticipated to witness significant growth in the coming years.

Central Venous Catheters:

Central Venous Catheters (CVCs) serve as essential tools in managing critically ill patients and those requiring extensive intravenous therapy. These catheters are inserted into larger veins, allowing for the administration of medications, fluids, and nutrition directly into the central circulation. The demand for CVCs is bolstered by the rising incidence of complex medical conditions that necessitate advanced vascular access solutions. Moreover, the increasing number of surgical procedures and critical care admissions further drives the central venous catheter market. Innovations in design and materials have also improved the safety and effectiveness of CVCs, resulting in a growing preference among healthcare facilities for these devices.

By Application

Medication Administration:

Medication administration is one of the primary applications of intravascular catheters, as they facilitate direct delivery of drugs into the bloodstream. The use of intravenous catheters for medication administration offers rapid therapeutic effects, which is crucial in emergency situations and for patients with severe conditions. The increasing prevalence of chronic diseases that require regular medication, such as diabetes and cancer, is significantly driving the demand for intravascular access devices. Furthermore, the development of specialized catheters designed for the administration of specific medications, including chemotherapy drugs, enhances their usability and effectiveness. As healthcare providers continue to emphasize the importance of effective medication delivery, the segment for medication administration is expected to grow steadily.

Fluid and Nutrition Administration:

The administration of fluids and nutrition through intravascular catheters is critical, particularly for patients unable to consume food orally or those requiring hydration during medical treatments. This application is increasingly relevant in acute care settings, such as hospitals and intensive care units, where rapid and efficient fluid replacement is essential. The rise in surgical procedures and the growing incidence of gastrointestinal disorders that necessitate parenteral nutrition are propelling the demand for intravascular catheters designed for fluid and nutrition administration. Innovations in catheter technology that ensure safer and more efficient delivery of fluids and nutrition contribute to the growth of this segment.

Blood Transfusion:

Blood transfusions are a vital component of emergency medical care and ongoing treatments for various medical conditions, making this application a significant driver of the intravascular catheters market. The use of specialized catheters for blood transfusions helps minimize the risk of complications, such as hemolysis and infections, ensuring patient safety. The rising number of surgical procedures and traumatic injuries requiring blood transfusions further amplifies the demand for intravascular catheters. Additionally, improvements in catheter design specifically for blood transfusion contribute to enhanced efficiency and safety, thereby bolstering the growth of this application segment in the market.

Monitoring:

Monitoring patients' hemodynamic status is critical for effective medical treatment, making the use of intravascular catheters essential in various healthcare settings. These catheters enable continuous or intermittent monitoring of central venous pressure, cardiac output, and other vital parameters. The increasing emphasis on patient safety and the need for accurate monitoring in critical care environments are driving the demand for advanced monitoring catheters. Additionally, technological advancements that integrate monitoring capabilities into catheter designs enhance their functionality and appeal to healthcare providers. As patient monitoring becomes increasingly sophisticated, the intravascular catheters used for this purpose are expected to see substantial growth.

By Distribution Channel

Hospitals:

Hospitals represent the dominant distribution channel for intravascular catheters, owing to their extensive utilization of these devices in various medical procedures. With the rising number of hospital admissions and surgical procedures, the demand for intravascular access devices is significantly heightened. Hospitals invest in high-quality catheter solutions to ensure patient safety and improve treatment outcomes, which drives the growth of this segment. The ongoing focus on infection control and patient safety protocols within hospitals also contributes to the adoption of advanced catheter technologies. As healthcare facilities continue to upgrade their equipment and practices, hospitals are expected to remain the primary channel for intravascular catheters.

Ambulatory Surgical Centers:

Ambulatory Surgical Centers (ASCs) are playing an increasingly significant role in the distribution of intravascular catheters as the trend towards outpatient care continues to rise. ASCs provide a variety of surgical and medical services on an outpatient basis, where intravascular catheters are routinely used for various procedures. The convenience and efficiency offered by ASCs, as well as the cost-effectiveness of outpatient procedures, are driving the demand for intravascular access devices in these settings. As more procedures move away from traditional hospital environments, the role of ASCs as distribution channels for intravascular catheters is expected to expand, creating new opportunities for market growth.

Specialty Clinics:

Specialty clinics, which focus on specific areas of care such as oncology, cardiology, and nephrology, are increasingly utilizing intravascular catheters to provide targeted treatments. These clinics often cater to patients requiring specialized therapies, including chemotherapy and dialysis, which necessitate reliable vascular access. The growing recognition of the importance of specialized care is boosting the demand for intravascular catheters in these facilities. Additionally, advancements in catheter technology that enhance performance and safety further increase their appeal to specialty clinics. As these clinics continue to expand and evolve, they are expected to become critical distribution channels for intravascular catheters.

Others:

The 'Others' category encompasses various distribution channels, including home healthcare services, rehabilitation centers, and long-term care facilities. This segment is gaining traction as the trend towards home-based healthcare continues to grow, particularly for patients requiring ongoing treatment and monitoring. In-home intravenous therapies are becoming more common, driving the demand for intravascular catheters designed for safe and efficient home use. Furthermore, the increasing preference for home healthcare solutions among patients and caregivers is expected to enhance the growth of this distribution channel. As healthcare delivery models shift towards more patient-centered approaches, the 'Others' category will likely see significant expansion.

By Material Type

Polyurethane:

Polyurethane is one of the most widely used materials in the production of intravascular catheters due to its excellent biocompatibility and flexibility. Catheters made from polyurethane are known for their durability and resistance to kinking, making them suitable for various applications, including fluid administration and medication delivery. The increasing preference for polyurethane catheters is driven by their ability to minimize complications associated with catheter use, such as infections and thrombosis. Additionally, advancements in polymer technology have led to the development of polyurethane catheters designed to enhance patient comfort and safety, further driving demand within this material segment.

Silicone:

Silicone is another popular material used in the manufacturing of intravascular catheters, particularly for long-term applications. Silicone catheters are known for their softness, flexibility, and reduced risk of thrombogenicity, making them ideal for prolonged vascular access. The increasing prevalence of chronic diseases requiring long-term treatment is driving the demand for silicone catheters, especially in oncology and critical care settings. Moreover, the biocompatibility of silicone ensures minimal irritation to surrounding tissues, enhancing patient comfort and safety. As healthcare providers continue to prioritize patient-centered care, the silicone segment is expected to see continued growth in the intravascular catheters market.

Polyethylene:

Polyethylene is commonly used in the production of intravascular catheters, particularly for short-term applications. The material is known for its cost-effectiveness and ease of processing, making it accessible for a wide range of healthcare settings. While polyethylene catheters may not possess the same level of flexibility and durability as polyurethane or silicone, they are widely used due to their simplicity and effectiveness. The increasing volume of outpatient procedures and short-term treatments is driving the demand for polyethylene catheters. As healthcare facilities continue to seek economical solutions for vascular access, this material segment will likely maintain its relevance in the market.

Teflon:

Teflon catheters are recognized for their excellent chemical resistance and low friction properties, making them suitable for specific medical applications. These catheters are often used in situations where reduced thrombogenicity and ease of insertion are crucial, such as in certain surgical procedures. The growing emphasis on minimizing complications associated with catheter use is driving the demand for Teflon catheters in specialized applications. However, the adoption of Teflon catheters is relatively limited compared to other materials, as they are primarily used in specific clinical situations rather than for general-purpose vascular access. Nonetheless, the unique properties of Teflon make it a valuable option in the intravascular catheters market.

Others:

The 'Others' category in material type encompasses various innovative materials being explored for intravascular catheters, including antimicrobial-coated materials and biodegradable polymers. These materials are gaining attention due to their potential to enhance catheter performance and safety by reducing infection rates and improving biocompatibility. The ongoing research and development in the field of catheter materials are expected to lead to the introduction of new products that cater to evolving healthcare needs. As technology advances and the demand for safer, more effective vascular access solutions grows, the 'Others' material segment is likely to gain prominence in the intravascular catheters market.

By Region

The North American region is expected to dominate the intravascular catheters market, accounting for approximately 40% of the total market share by 2035. The well-established healthcare infrastructure and high healthcare expenditure in the United States and Canada contribute significantly to this dominance. Moreover, the presence of key market players and ongoing innovations in catheter technology further solidify North America's position in the global market. The increasing prevalence of chronic diseases and the rising number of surgical procedures within the region are additional factors propelling market growth. The North American market is projected to grow at a CAGR of 8.0% during the forecast period, indicating strong future prospects.

Europe is anticipated to follow North America, holding around 30% of the intravascular catheters market by 2035. The region's aging population and the growing prevalence of chronic diseases are significant drivers of market growth. Countries such as Germany, France, and the UK are witnessing increased investments in healthcare infrastructure and technology, which will enhance the adoption of advanced intravascular catheters. Additionally, the rising trend of outpatient surgical procedures is expected to fuel the demand for these devices across Europe. As healthcare systems continue to innovate and evolve, the European intravascular catheters market is expected to experience steady growth, driven by a focus on improved patient outcomes and safety. Overall, the global intravascular catheters market is set for remarkable expansion, supported by technological advancements and a rising demand for effective vascular access solutions.

Opportunities

The intravascular catheters market presents numerous opportunities for growth, particularly in emerging economies where healthcare infrastructure is rapidly evolving. As countries in Asia-Pacific, Latin America, and the Middle East invest in modernizing their healthcare systems, the demand for advanced medical devices, including intravascular catheters, is expected to increase significantly. The rising awareness of chronic diseases and the demand for effective treatment options will drive healthcare providers in these regions to adopt innovative catheter technologies. Moreover, government initiatives aimed at improving healthcare access and quality will further support market growth, offering lucrative opportunities for both existing and new market entrants looking to establish a presence in these regions.

Furthermore, the increasing trend towards home healthcare and outpatient services is creating new avenues for the intravascular catheters market. With more patients receiving treatments at home or in outpatient settings, there is a growing need for versatile and user-friendly catheter solutions that can be easily managed by patients and caregivers. Innovative designs that enhance safety and minimize the risk of complications will be particularly appealing to this demographic. As healthcare providers continue to prioritize patient-centered care and explore alternative delivery models, the intravascular catheters market will continue to benefit from these evolving trends, providing ample opportunities for growth and development.

Threats

Despite the promising growth prospects for the intravascular catheters market, several threats could impact its expansion. One major concern is the increasing regulatory scrutiny of medical devices, which may lead to delays in product approvals and increased compliance costs for manufacturers. Stricter regulations and guidelines surrounding the production and use of intravascular catheters could impede market entry for new players and limit the availability of innovative products. Additionally, the rising awareness of catheter-related complications, such as infections and thrombosis, may prompt healthcare providers to reconsider their use of intravascular catheters, impacting overall demand. Manufacturers must continuously address these concerns by implementing stringent quality control measures and investing in research and development to enhance safety and efficacy.

Another significant threat to the intravascular catheters market is the increasing competition from alternative vascular access devices, such as implantable ports and newer technologies like wireless catheters. As advancements in medical technology progress, these alternatives may provide superior performance and address some of the limitations associated with traditional intravascular catheters. This competitive landscape may pressure existing market players to innovate and differentiate their products to maintain market share. Additionally, the ongoing trend towards minimally invasive procedures can result in reduced demand for certain types of catheters, further challenging manufacturers to adapt to changing market dynamics.

Competitor Outlook

• BD (Becton, Dickinson and Company)
• Medtronic plc
• Smiths Medical
• Cardinal Health
• Terumo Corporation
• Cook Medical
• Boston Scientific Corporation
• Teleflex Incorporated
• Halyard Health
• HemoSonics
• Vygon SA
• Ethicon (Johnson & Johnson)
• Fresenius Kabi
• ConvaTec Group
• Amecath

The competitive landscape of the intravascular catheters market showcases a diverse array of companies vying for market share. Major players such as BD, Medtronic, and Smiths Medical are continuously investing in research and development to innovate and enhance their product offerings. These companies leverage their extensive experience and established reputations to maintain a competitive edge. Furthermore, partnerships and collaborations with healthcare providers and technology companies are common strategies employed by these key players to access new markets and expand their reach. The emphasis on product safety, efficacy, and patient comfort remains a primary focus as companies strive to offer solutions that meet evolving healthcare needs.

Companies like Terumo and Cook Medical are notable for their innovations in catheter technologies, including the development of advanced materials and designs aimed at minimizing catheter-related complications. They are also actively engaging in clinical studies to validate the effectiveness of their products, thereby enhancing their credibility in the market. In addition, these companies are focusing on enhancing their distribution channels, ensuring that their products are accessible to healthcare providers globally. As the intravascular catheters market continues to grow, the competitive landscape will likely witness increased activity from both established players and new entrants seeking to capitalize on emerging opportunities.

Several companies, such as Teleflex and Cardinal Health, are also making significant strides in the intravascular catheters market through targeted marketing strategies and a focus on customer education. By providing comprehensive training and support to healthcare providers, these companies aim to improve the safe and effective use of their products. Additionally, they are actively involved in initiatives that promote best practices in catheter management and infection prevention. As awareness of catheter-related complications grows, these efforts will play a crucial role in cementing the trust of healthcare providers and patients in their products, fostering long-term relationships and customer loyalty.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Amecath
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Vygon SA
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 HemoSonics
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Cook Medical
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Medtronic plc
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 ConvaTec Group
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Fresenius Kabi
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Halyard Health
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Smiths Medical
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Cardinal Health
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Terumo Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Teleflex Incorporated
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Ethicon (Johnson & Johnson)
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Boston Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 BD (Becton, Dickinson and Company)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Intravascular Catheters Market, By Application
    • 6.1.1 Medication Administration
    • 6.1.2 Fluid and Nutrition Administration
    • 6.1.3 Blood Transfusion
    • 6.1.4 Monitoring
  • 6.2 Intravascular Catheters Market, By Product Type
    • 6.2.1 Short PIVCs
    • 6.2.2 Integrated Catheters
    • 6.2.3 Midline Catheters
    • 6.2.4 PICCs
    • 6.2.5 Central Venous Catheters
  • 6.3 Intravascular Catheters Market, By Material Type
    • 6.3.1 Polyurethane
    • 6.3.2 Silicone
    • 6.3.3 Polyethylene
    • 6.3.4 Teflon
    • 6.3.5 Others
  • 6.4 Intravascular Catheters Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Ambulatory Surgical Centers
    • 6.4.3 Specialty Clinics
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Intravascular Catheters Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Intravascular Catheters market is categorized based on

By Product Type

• Short PIVCs
• Integrated Catheters
• Midline Catheters
• PICCs
• Central Venous Catheters

By Application

• Medication Administration
• Fluid and Nutrition Administration
• Blood Transfusion
• Monitoring

By Distribution Channel

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Material Type

• Polyurethane
• Silicone
• Polyethylene
• Teflon
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• BD (Becton, Dickinson and Company)
• Medtronic plc
• Smiths Medical
• Cardinal Health
• Terumo Corporation
• Cook Medical
• Boston Scientific Corporation
• Teleflex Incorporated
• Halyard Health
• HemoSonics
• Vygon SA
• Ethicon (Johnson & Johnson)
• Fresenius Kabi
• ConvaTec Group
• Amecath